Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06830577

Intra-ureteric Aminophylline Instillation on Flexible Ureteroscopy Procedure

Efficacy of Intra-ureteric Aminophylline Instillation on Flexible Ureteroscopy Procedure: A Randomized Controlled Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
129 (estimated)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

in this study we are going to evaluate the efficacy of intra-ureteric aminophylline instillation in facilitating ureteric access sheath placement prior to flexible ureteroscopy in reducing ureteric injury rates.

Detailed description

Urolithiasis (kidney and ureteral stones) is a common urologic condition with increasing prevalence. Flexible ureteroscopy (FURS) is a minimally invasive technique widely used for upper ureteric and renal stones. Aminophylline, a methylxanthine derivative, has been shown to relax smooth muscles and was previously used intravesically to facilitate rigid ureteroscopy with reduced complications. This study aims to assess whether intra-ureteric aminophylline instillation improves the ease of ureteral access sheath (UAS) placement during FURS and reduces ureteric injuries. patients will be divided into 3 groups: 1. Group A (Aminophylline Group): Intra-ureteric instillation of aminophylline 2. Group B (Ureteral Dilator Group): Traditional ureteral dilators 3. Group C (Combination Group): Aminophylline instillation + Ureteral dilators follow up of the patients will be through the success rate or failure of ureteric access sheath placement, operative time, bleeding, intra/postoperative complications and stone clearance (3-week follow-up with CT scan)

Conditions

Interventions

TypeNameDescription
DRUGUsage of Aminophylline prior to ureteric dilatation in Flexible uretroscopyIntraureteric aminophylline installation prior to ureteric dilatation
DEVICESequential teflon dilator usage prior to ureteric access sheath placement in flexible uretroscopytraditional ureteral dilators will be used. We will start by ureteral dilator 6 fr and gradually increase the size up to 12 Fr
OTHERAminophylline instillation and Ureteral dilators togetherAminophylline will be instilled as in group (A) then followed by traditional ureteral dilatation as in group (B) prior to placing the ureteric access sheath

Timeline

Start date
2025-03-01
Primary completion
2026-01-01
Completion
2026-02-01
First posted
2025-02-17
Last updated
2025-06-12

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06830577. Inclusion in this directory is not an endorsement.